Corpay (NYSE:CPAY) versus Cannabis Wheaton Income (OTCMKTS:CBWTF) Critical Survey

Cannabis Wheaton Income (OTCMKTS:CBWTF) and Corpay (NYSE:CPAY) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, earnings, profitability, dividends, risk and institutional ownership.

Profitability

This table compares Cannabis Wheaton Income and Corpay’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Cannabis Wheaton Income	20.99%	19.84%	12.26%
Corpay	24.60%	38.68%	6.46%

Earnings & Valuation

This table compares Cannabis Wheaton Income and Corpay”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cannabis Wheaton Income	$108.41 million	1.67	$29.96 million	$0.02	6.38
Corpay	$4.78 billion	5.43	$1.07 billion	$16.71	23.77

Corpay has higher revenue and earnings than Cannabis Wheaton Income. Cannabis Wheaton Income is trading at a lower price-to-earnings ratio than Corpay, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Cannabis Wheaton Income and Corpay, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cannabis Wheaton Income	0	0	0	0	0.00
Corpay	0	3	12	0	2.80

Corpay has a consensus price target of $383.69, suggesting a potential downside of 3.41%. Given Corpay’s stronger consensus rating and higher probable upside, analysts plainly believe Corpay is more favorable than Cannabis Wheaton Income.

Institutional and Insider Ownership

98.8% of Corpay shares are owned by institutional investors. 4.6% of Cannabis Wheaton Income shares are owned by insiders. Comparatively, 5.2% of Corpay shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Risk & Volatility

Cannabis Wheaton Income has a beta of 1.39, indicating that its share price is 39% more volatile than the S&P 500. Comparatively, Corpay has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500.

Summary

Corpay beats Cannabis Wheaton Income on 12 of the 14 factors compared between the two stocks.

About Cannabis Wheaton Income

Auxly Cannabis Group Inc. operates as a consumer packaged goods company in the cannabis products market in Canada. It focuses on developing, manufacturing, and distributing cannabis products for wellness and recreational consumers. The company offers cannabis products under various forms, including vape catridges, infused pre-rolls, pre-rolled, vape pens, milled and dried flower, concentrates, chocolates, soft chews, oil drops, capsules, and topicals under the KOLAB PROJECT, Dosecann, BACK FORTY, Foray, and Parcel brand names. It sells its products through supply arrangements with provincial control boards and distributors, medical cannabis sales channels, and retailers, as well as to authorized wholesalers. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. The company was incorporated in 1987 and is headquartered in Toronto, Canada.

About Corpay

Volatus is a leader in innovative global aerial solutions for intelligence and cargo. With over 100 years of combined institutional knowledge in aviation, Volatus provides comprehensive solutions using both piloted and remotely piloted aircraft systems for a wide array of industries, including oil and gas, energy utilities, healthcare, public safety, and infrastructure. The Company is committed to enhancing operational efficiency, safety, and sustainability through cutting-edge aerial technologies.